tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer.

Weigang LiuMengqian YuSheng ChengXiaoxu ZhouJia LiYan LuPengyuan LiuShiping Ding

Published in: Current oncology (Toronto, Ont.) (2023)

5'-tRFs are potential clinical biomarkers for the diagnosis, prognosis, and classification of tumor subtypes on a molecular level. These can help clinicians formulate personalized treatment plans for PRAD patients and may have similar potential applications for other disease types.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
machine learning
palliative care
health insurance